IP Library Granted Patent US 10,488,396
Granted Patent B2
US 10,488,396 · App. 15/640,852 · Granted Nov 26, 2019

Apparatus, method, system for the determination of the aggregation rate of red blood cells

Inventors: Peter Sacchetti (Attleboro, MA); Francesco Frappa (Udine, IT)
Assignee: Alcor Scientific, Inc.
G01N33/4905G01N15/05G01N21/51G01N33/4915G01N2015/0073G01N2015/0092
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,488,396
App. No.
15/640,852
Granted
Nov 26, 2019
Kind
B2
Abstract

The present invention generally relates to an apparatus, method, system for the determination of the aggregation rate of red blood cells. More specifically, the invention concerns a method, system, and the relative apparatus used to determine the aggregation rate of red blood cells, and other parameters related to these, such as viscosity, deformability, elasticity, density, in the field of in vitro medical analyses, using optical systems after or during inducted forces for red blood cell disruption and redistribution generated by ultrasound waves.

Claims (12)

1. An apparatus for determining the aggregation rate of red blood cells comprising:

(a) an optical receiver positioned to detect light from a blood sample portion comprising red blood cells that have aggregated;

(b) a main controller coupled to the optical receiver for recording an aggregation rate of the red blood cells of the blood sample portion upon detected light variation;

(c) a hydraulic circuit for providing the blood sample portion;

(d) a light emitter source to pass light into the blood sample portion;

(e) a reading cell container connected to the hydraulic circuit for receiving the blood sample portion; and

(f) a disruption mechanism connected to the reading cell container for disruption of the red blood cells within the blood sample portion to assist in recording the disruption rate, wherein the main controller activates the disruption mechanism for the disruption of the red blood cells within the blood sample portion until light detected indicates the disruption of aggregate within the blood sample portion.

2. The apparatus of claim 1 , wherein the apparatus comprises:

an evacuation mechanism to evacuate the evacuated blood sample portion from the reading cell container,

wherein the evacuation mechanism is configured to provide ultrasound stress to the reading cell container.

3. The apparatus of claim 1 , wherein the apparatus determines a disruption index of the red blood cells as rheological parameters usable for pathologic detection purposes.

4. The apparatus of claim 1 , wherein the apparatus determines a mean red blood cells shape recovery ability.

Assignments (3)
CHANGE OF NAME Recorded Feb 20, 2024
From: ALCOR SCIENTIFIC, INC
To: ALCOR SCIENTIFIC, LLC
Reel/Frame 066626/0978 →
SECURITY INTEREST Recorded Jan 31, 2022
From: AQUARIUS INTERMEDIATE LLC; ALCOR SCIENTIFIC LLC
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 058825/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2017
From: SACCHETTI, PETER; FRAPPA, FRANCESCO
To: ALCOR SCIENTIFIC, INC.
Reel/Frame 043230/0345 →
Continuity (5)
Continuation 15003272 · Jan 21, 2016
Continuation 14176307 · Feb 10, 2014
Continuation 13740843 · Jan 14, 2013
Provisional Application 61586502 · Jan 13, 2012
Related Publication 20170299575A1 · Oct 19, 2017
Cited By (1)
US 12,637,652